Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 4:7:e7252.
doi: 10.7717/peerj.7252. eCollection 2019.

The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study

Affiliations

The prognostic impact of age in different molecular subtypes of breast cancer: a population-based study

Dongjun Dai et al. PeerJ. .

Abstract

Background: The aim of current study was to use competing risk model to calculate the potential differences that age played in the prognosis of different breast cancer subtypes.

Methods: The cohort was selected from Surveillance, Epidemiology, and End Results (SEER) program. The cumulative incidences of death (CID) was assessed for breast cancer caused deaths and other causes of mortality. The multivariate Cox proportional hazards regression model and the multivariate subdistribution hazard (SH) model were used to evaluate the prognostic value of age in different breast cancer subtypes.

Results: We involved 33,968 breast cancer patients into our cohort. We found older patients had worse overall survival (OS) than young patients in hormone receptor positive and human epidermal growth factor receptor 2 positive breast cancer (HR+/HER2+) (≥40 vs. <40, HR = 2.07, 95% CI [1.28-3.35], p < 0.05). However, when we used competing risk model, we found young age was an independent risk factor only for triple negative breast cancer (TNBC) (≥40 vs. <40, HR = 0.71, 95% CI [0.56-0.89], p < 0.05). No association was found in other groups.

Conclusion: Our research was currently the largest sample size study and the first competing risk model-based study on the prognostic association between age and different breast cancer subtypes. We found <40 years patients had worse breast cancer specific survival (BCSS) than older patients in the TNBC subtype.

Keywords: Age; Breast cancer specific survival; Competing risk model; Molecular subtype; Prognosis; Triple negative breast cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare there are no competing interests.

Figures

Figure 1
Figure 1. Univariate analysis based on the competing risk regression model.
The association between age and breast cancer in all cohort (A), HR+ group (D), and molecular subtypes (C–F).

References

    1. Abdulkareem IH, Zurmi IB. Review of hormonal treatment of breast cancer. Nigerian Journal of Clinical Practice. 2012;15:9–14. doi: 10.4103/1119-3077.94088. - DOI - PubMed
    1. Albrektsen G, Heuch I, Hansen S, Kvale G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. British Journal of Cancer. 2005;92:167–175. doi: 10.1038/sj.bjc.6602302. - DOI - PMC - PubMed
    1. Alluri P, Newman LA. Basal-like and triple-negative breast cancers: searching for positives among many negatives. Surgical Oncology Clinics of North America. 2014;23:567–577. doi: 10.1016/j.soc.2014.03.003. - DOI - PMC - PubMed
    1. Anders CK, Fan C, Parker JS, Carey LA, Blackwell KL, Klauber-DeMore N, Perou CM. Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes? Journal of Clinical Oncology. 2011;29:e18–e20. doi: 10.1200/JCO.2010.28.9199. - DOI - PMC - PubMed
    1. Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. Journal of Clinical Oncology. 2008;26:3324–3330. doi: 10.1200/JCO.2007.14.2471. - DOI - PubMed